PQ Insights

This week’s EU health policy developments: cross-border healthcare, regulation of medicines and pesticides, and oversight of national recovery funds.

This week’s EU health policy developments: regulation and transparency for medicines; prevention for public health; safety for food and chemicals

This week’s EU health policy: focus on workforce and access, regulation of medicines and data, AI governance, and environmental health and safety.

This week’s EU health policy developments: workforce challenges, public health prevention, medicines regulation, and environment-health links.

This week’s EU health policy developments span youth mental health, medical device and chemical regulation, and environmental health — with new Commission answers on Lyme diagnostics, ethanol classification, and EU-US tariff exemptions for pharmaceuticals.

This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.

This week’s EU health policy developments range from new mental health initiatives and the Pfizergate transparency case to waste disposal risks, Green Deal health impacts, and Mercosur trade concerns — all based on verified institutional sources.

Overview This report summarises key Parliamentary Questions (PQs) submitted during the June – July 2025 period. The inquiries cover a diverse range of policy areas, with significant focus on public health and security, including women’s health and gain-of-function research; agriculture and environmental policy, with questions on the future of the CAP and water management; foreign […]

This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.

This week’s EU health and governance developments range from healthcare access and ME/CFS research to glyphosate safety, burnout prevention, and humanitarian issues in Gaza. The Commission’s replies highlight growing focus on patient rights, vaccine safety, disability inclusion, and transparency in EU governance.